Takeda Pharmaceutical Co Ltd (TAK) EBITDA Margin (2018 - 2026)
Takeda Pharmaceutical (TAK) reported EBITDA Margin of 29.88% for the quarter ended Jun 30, 2026, down 3.21 percentage points from 33.09% a year earlier and down 2.45 percentage points from the prior quarter.
Takeda Pharmaceutical Co Ltd (TAK) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's EBITDA Margin came in at 22.86%, down 5.82 percentage points year-over-year; for the year ended Mar 31, 2026, it was 16.14%, down 7.95 percentage points from the prior year.
- EBITDA Margin has a five-year change of -17.28 percentage points (years ended Mar 2021 to Mar 2026).
- By year, EBITDA Margin came in at 24.10% in the year ended Mar 31, 2025 (+2.00 pp), 22.09% in the year ended Mar 31, 2024 (-6.58 pp), 28.68% in the year ended Mar 31, 2023 (-0.58 pp) and 29.25% in the year ended Mar 31, 2022 (-4.18 pp).
- Five-year quarterly EBITDA Margin spans a low of -20.61% in the quarter ended Dec 31, 2025 and a high of 64.79% in the quarter ended Sep 30, 2022.
- Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -6.18 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was the quarter ended Jun 30, 2025 (a gain of 3.41 percentage points); the low point was the quarter ended Sep 30, 2023 (a drop of 31.26 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 32.33% (quarter ended Mar 31, 2026), -20.61% (quarter ended Dec 31, 2025) and 30.45% (quarter ended Sep 30, 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.88% |
| Mar 31, 2026 | 32.33% |
| Dec 31, 2025 | -20.61% |
| Sep 30, 2025 | 30.45% |
| Jun 30, 2025 | 33.09% |
| Mar 31, 2025 | 33.34% |
| Dec 31, 2024 | 10.64% |
| Sep 30, 2024 | 30.98% |
| Jun 30, 2024 | 29.68% |
| Mar 31, 2024 | 32.02% |
| Dec 31, 2023 | 26.23% |
| Sep 30, 2023 | 33.53% |
| Jun 30, 2023 | 32.12% |
| Mar 31, 2023 | 32.86% |
| Dec 31, 2022 | 29.54% |
| Sep 30, 2022 | 64.79% |
| Jun 30, 2022 | 31.75% |
| Jun 30, 2021 | 41.23% |
| Mar 31, 2021 | 50.36% |
| Jun 30, 2020 | 38.52% |
Takeda Pharmaceutical Co Ltd EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();